Letter of response to Professor Dalgleish regarding our paper Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene

Osteoporos Int. 2022 Jun;33(6):1405. doi: 10.1007/s00198-022-06332-y. Epub 2022 Mar 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Anabolic Agents*
  • Bone Density Conservation Agents* / pharmacology
  • Bone Density Conservation Agents* / therapeutic use
  • Humans
  • Osteoporosis* / drug therapy
  • Osteoporosis* / genetics

Substances

  • Anabolic Agents
  • Bone Density Conservation Agents